Home - Products - Others - Other Targets - Uremic Pentapeptide (U5-Peptide)

Uremic Pentapeptide (U5-Peptide)

CAS No. 71494-20-7

Uremic Pentapeptide (U5-Peptide)( ——— )

Catalog No. M42216 CAS No. 71494-20-7

Uremic Pentapeptide (U5-Peptide)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Uremic Pentapeptide (U5-Peptide)
  • Note
    Research use only, not for human use.
  • Brief Description
    Uremic Pentapeptide (U5-Peptide)
  • Description
    Uremic Pentapeptide (U5-Peptide)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    71494-20-7
  • Formula Weight
    688.8
  • Molecular Formula
    C32H48N8O9
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dibutyl phthalate

    Dibutyl phthalate is a plasticizer used in most plastics and found in water air soil plants and animals. It may have some adverse effects with long-term exposure.

  • Isothymusin

    Isothymusin( MIC= 200 microg/mL) exhibits inhibition activity against Mycobacterium tuberculosis. It ( IC50=7.7 microg/mL ) exhibits antioxidant activity against the radical scavenging ability of DPPH.

  • Exendin-4 (3-39)

    Exendin-4 (3-39) is a peptide. Exendin-4 (3-39) is a truncated form of Exendin-4 that lacks the first two amino acids. Exendin-4 is a potent Glucagon-like peptide-1 receptor (GLP-1r) agonist. Exendin-4 (3-39) and Exendin-4 can be used for the research of diabetic and hypothalamic-pituitary-adrenal (HPA) axis.